Navigation Links
Study Shows Ixabepilone Demonstrated Clear Activity in Patients,with Metastatic Breast Cancer Resistant to Anthracycline, Taxane,,and Capecitabine

lt of new information, future events or otherwise.

CONTACT: Media, Madeline Malia, Media Communications, +1-609-252-3347office, +1-609-651-1323 mobile, , or Jeff Macdonald,Media Communications, +1-917-371-0940 mobile, , orInvestors, John Elicker, Investor Relations, +1-212-546-3775,, all of Bristol-Myers Squibb madeline.malia@bms.com jeffrey.macdonald@bms.com john.elicker@bms.com

Web site: http://www.bms.com/http://www.jco.org/http://www.clinicaltrials.gov/

Ticker Symbol: (NYSE:BMY)

Terms and conditions of use apply
Copyright © 2007 PR Newswire Association LLC. All rights reserved.
A United Business Media Company


'"/>




Page: 1 2 3 4

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. Reaction to Avandia Warnings Stronger Among Internists Than Endocrinologists, According to Study by GfK Market Measures
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
8. Protox Announces Positive Clinical Data from Prostate Cancer Study
9. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
10. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
11. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
Post Your Comments:
(Date:5/22/2012)... -- Health Diagnostic Laboratory, Inc. (HDL, Inc.), a CAP ... Lipid Association (NLA) with a non-restricted educational grant to ... cardiovascular health across the United States. In addition to ... the lead sponsors of the 2012 Annual Scientific Sessions ... 3, 2012. "Health Diagnostic Laboratory knows ...
(Date:5/22/2012)... May 22, 2012  Boehringer Ingelheim announced ... evaluating the investigational compound tiotropium delivered once-daily ... adolescents with symptomatic, moderate persistent asthma. The ... Meeting of the American Thoracic Society (ATS ... confirmatory Phase III trial program named UniTinA-asthma™ ...
(Date:5/22/2012)... /PRNewswire-iReach/ -- APEX BIOSTRATEGISTS, A FULL SERVICE ... THE RECENT ASSET SALE BY NPE SYSTEMS, INC. AND ... TO BECKMAN COULTER. NPE AND BLUE OCEAN WERE TECHNOLOGY ... DIAGNOSTIC BLOOD AND TISSUE TESTING FOR PATIENT MONITORING AND ... IN THE SALE OF FLOW CYTOMETRY SYSTEMS TO HOSPITALS ...
Breaking Medicine Technology:Health Diagnostic Laboratory, Inc. Provides Grant to Support National Lipid Association, Sponsors 2012 Annual Scientific Sessions in Scottsdale, Arizona 2Boehringer Ingelheim Presents First Data for Tiotropium in Adolescents with Moderate Persistent Asthma 2Boehringer Ingelheim Presents First Data for Tiotropium in Adolescents with Moderate Persistent Asthma 3Boehringer Ingelheim Presents First Data for Tiotropium in Adolescents with Moderate Persistent Asthma 4Apex BioStrategists Advises On Flow Cytometry Sale To Coulter 2Mindray Medical to Present at the Morgan Stanley Global Healthcare Conference 10431 1Mindray Medical to Present at the Morgan Stanley Global Healthcare Conference 10431 2Mindray Medical to Present at the Morgan Stanley Global Healthcare Conference 10431 3Mindray Medical to Present at the Morgan Stanley Global Healthcare Conference 10431 4Mindray Medical to Present at the Morgan Stanley Global Healthcare Conference 10431 5Mindray Medical to Present at the Morgan Stanley Global Healthcare Conference 10431 6Fosun Pharma Acquires 2414 Million of Chindex Stock 10428 1Fosun Pharma Acquires 2414 Million of Chindex Stock 10428 2Fosun Pharma Acquires 2414 Million of Chindex Stock 10428 3Fosun Pharma Acquires 2414 Million of Chindex Stock 10428 4Fosun Pharma Acquires 2414 Million of Chindex Stock 10428 5Fosun Pharma Acquires 2414 Million of Chindex Stock 10428 6Fosun Pharma Acquires 2414 Million of Chindex Stock 10428 7Fosun Pharma Acquires 2414 Million of Chindex Stock 10428 8Fosun Pharma Acquires 2414 Million of Chindex Stock 10428 9A step toward a new sunscreen 3F 15110 1A step toward a new sunscreen 3F 15110 2A step toward a new sunscreen 3F 15110 3
... Age: Comparison by Interventional Radiologists Shows No Difference ... DIEGO, March 9 A new study shows ... it doesn,t matter if you,re young or old: ... maintaining access to one,s circulatory system to provide ...
... dosed every two weeks met the primary efficacy ... alfa-2a dosed weekly in patients with genotype 1 ... Albuferon had comparable rates of serious and/or severe ... global marketing applications planned in fall 2009 -ROCKVILLE, ...
Other Medicine Technology:For Old or Young Dialysis Patients, AV Fistulas Remain Pure Gold 2For Old or Young Dialysis Patients, AV Fistulas Remain Pure Gold 3For Old or Young Dialysis Patients, AV Fistulas Remain Pure Gold 4Human Genome Sciences Announces Positive Results in Second of Two Phase 3 Trials of Albuferon(R) in Chronic Hepatitis C 2Human Genome Sciences Announces Positive Results in Second of Two Phase 3 Trials of Albuferon(R) in Chronic Hepatitis C 3Human Genome Sciences Announces Positive Results in Second of Two Phase 3 Trials of Albuferon(R) in Chronic Hepatitis C 4Human Genome Sciences Announces Positive Results in Second of Two Phase 3 Trials of Albuferon(R) in Chronic Hepatitis C 5Human Genome Sciences Announces Positive Results in Second of Two Phase 3 Trials of Albuferon(R) in Chronic Hepatitis C 6Human Genome Sciences Announces Positive Results in Second of Two Phase 3 Trials of Albuferon(R) in Chronic Hepatitis C 7Human Genome Sciences Announces Positive Results in Second of Two Phase 3 Trials of Albuferon(R) in Chronic Hepatitis C 8Human Genome Sciences Announces Positive Results in Second of Two Phase 3 Trials of Albuferon(R) in Chronic Hepatitis C 9Human Genome Sciences Announces Positive Results in Second of Two Phase 3 Trials of Albuferon(R) in Chronic Hepatitis C 10
(Date:5/23/2012)... risk of sudden cardiac death is higher in men ... chambers of the heart, a new study indicates. ... to pump blood through its four chambers. The impulses, ... using an electrocardiogram (ECG). The waves traveling through the ... as the "QRS" complex. In the new study, ...
(Date:5/23/2012)... most comprehensive analyses to date of the cost of ... found that this now-dominant surgical approach is significantly more ... of long-term improved patient outcomes. The results of the ... July issue of the journal Urology . ... actual direct and indirect costs at a single institutionrather ...
(Date:5/23/2012)... nerve connections as we age help keep us sharp in ... has found. , Older people with robust brain ,wiring, ... areas can process information quickly and that this makes ... the findings, joining distant parts of the brain together with ... found in a single part of the brain. , ...
(Date:5/23/2012)... (HealthDay News) -- The use of physical restraints ... multi-pronged approach that includes more training and supportive ... a new German study. Despite legal regulations ... such as bed rails and belts still are ... found that the rate of physical-restraint use in ...
(Date:5/23/2012)... present findings on prostate cancer risk, screening, treatment ... of the American Urological Association May 19-23 in ... to provide expert comment for reporters covering the ... presented and their embargo dates include: , ... surgery hormone therapy , Embargoed until 10:30 a.m. ...
Breaking Medicine News(10 mins):Health News:Study Spots Early Warning Signal for Sudden Cardiac Death 2Health News:Robotic-assisted prostate cancer surgery drives up costs, UPMC study finds 2Health News:Robotic-assisted prostate cancer surgery drives up costs, UPMC study finds 3Health News:Well-connected brains make you smarter in older age 2Health News:Study Offers Ways to Decrease Use of Restraints at Nursing Homes 2Health News:Mayo Clinic urologists present findings at American Urological Association Annual Meeting 2Health News:Mayo Clinic urologists present findings at American Urological Association Annual Meeting 3Health News:Mayo Clinic urologists present findings at American Urological Association Annual Meeting 4
... that The World Bank did not aid the fight against ... of $500 million// to combat malaria. In addition, the bank ... and resources in hand to see an initiative of such ... used for the program were ineffective in meeting the desired ...
... brain during brain tumor surgery was found to be ... the damage to speech and language centers, which happens// ... ,According to researchers, "intraoperative language mapping" involves operating on ... patient's language function during the procedure. This helps surgeons ...
... in her hospital bed in ward 3 of Middlemore Hospital, ... her. Except for a constant// feeling of thirst, a craving ... of dizziness she had been fine. She was surprised to ... GP. The blood tests revealed that her blood sugar levels ...
... ago still holds more than a third of Britain prey ... to cause cancer in children according to the investigation led ... measurements published in the report at least 34 per cent ... a result of the disaster. ,This has been ...
... milk during pregnancy probably to limit weight gain or due ... the womb. ,The results of the study were ... part in the study. All were non-smokers. However, on comparison ... at least a cup of milk a day during pregnancy ...
... According to the researchers, a vaginal gel, which is said ... against HIV, the virus that causes AIDS// expected to hit ... gels are being tested in a number of clinical trials ... years, the Associated Press reported. ,According to foodconsumer.org, ...
Other Medicine News:Health News:Diabetes, The Silent Killer of New Zealand 2Health News:Diabetes, The Silent Killer of New Zealand 3Health News:Limiting milk can hamper Babies’ Growt 2
ArcticTemp Upright Freezer -20C. Quick, even freezing. Heavy duty compressor. Deep door racks. Front gated bottom shelf. Interior light. Locks One year warranty on unit and 5 year warranty on compres...
Digital Thermostat. , Exteriorbaked enamel-on-steel. , Interiorwhite anodized aluminum. , Electronic temperature control. , Temperature -20C , Positive seal doors. , Keyed door lock. , Interi...
... accurate portable, waterproof system for pH, mV (ORP), ... results can be obtained when used with a ... This GLP/GMP compliant system includes an RS-232 interface ... Up to 100 data sets can be stored ...
... portable system for pH, mV (ORP), relative mV ... be obtained when used with a temperature probe ... compliant system includes an RS-232 interface to connect ... 100 data sets can be stored for later ...
Medicine Products: